Document is current
Any future updates will be listed below
-
Authors
Buckley, Hannah L.
Collinson, Fiona J.
Ainsworth, Gemma
Poad, Heather
Flanagan, Louise
Katona, Eszter
Howard, Helen C.
Murden, Geraldine
Banks, Rosamonde E.
Brown, Joanne
Velikova, Galina
Waddell, Tom
Fife, Kate
Nathan, Paul D.
Larkin, James
Powles, Thomas
Brown, Sarah R.
Vasudev, Naveen S. http://orcid.org/0000-0001-8470-7481
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb (CA209-814)
- License Information
-
More Information
Article History
Received: 19 August 2019
Accepted: 18 October 2019
First Online: 14 November 2019
Ethics approval and consent to participate
: The trial has received ethics approval from the NHS National Research Ethics Service (NRES) Yorkshire and The Humber Leeds East Research Ethics Committee (Ref: CitationRef removed/YH/0187). All participating sites require site specific approval before opening to patient recruitment. All participants provide full informed consent to participate in PRISM.
: Not applicable.
: TW, KF, JL, PN, TP and NV have received advisory fees and / or speaker honoraria from Bristol Myers Squibb. This trial is funded by Bristol-Myers Squibb, a global biopharmaceutical company. All other authors declare that they have no competing interests.
